Internal Medicine, Rheumatology · Houston, TX
NPI
1457344202
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
7401 Main St
Houston, TX, 77030
Phone (713) 799-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
204,844 services
Medicare patients, 2024
514
Average age 72
Drug cost, 2024
$4.4M
2,792 prescriptions
Company payments, 2024
$185
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Holly J Jones was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 62,000 times for 21 patients. In total Holly J Jones billed 204,844 services in 64 codes, and Medicare paid $2.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 62,000 | 21 | $3.61 | $224K |
| J3262 Injection, tocilizumab, 1 mg | Office | 51,802 | 16 | $4.70 | $244K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 29,873 | 41 | $9.02 | $269K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 9,150 | 20 | $33.41 | $306K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 6,179 | 18 | $24.86 | $154K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,165 | 24 | $0.10 | $525 |
| J0897 Injection, denosumab, 1 mg | Office | 3,540 | 35 | $20.29 | $72K |
| J9312 Injection, rituximab, 10 mg | Office | 3,000 | 11 | $50.95 | $153K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,383 | 17 | $0.22 | $301 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 538 | 329 | $12.94 | $6,960 |
| 99213 Office E&M - Established | Office | 512 | 335 | $64.85 | $33K |
| 96372 Injection Administration | Office | 441 | 83 | $11.22 | $4,947 |
| 99214 Office E&M - Established | Office | 355 | 256 | $89.50 | $32K |
| 96413 Chemotherapy Administration | Office | 339 | 87 | $99.92 | $34K |
| 96365 Intravenous Infusion, Hydration | Office | 296 | 64 | $49.21 | $15K |
By year: 2022 $1.9M for 165,446 services; 2023 $1.7M for 171,912 services; 2024 $2.1M for 204,844 services.
Medicare prescription drug claims, 2024
In 2024, the drug Holly J Jones prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 719 prescriptions and refills. In total Holly J Jones wrote 2,792 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 719 | 1,981 | 259 | $37K |
| Prednisone Generic | 398 | 600 | 174 | $3,060 |
| Methotrexate Methotrexate Sodium | 266 | 715 | 108 | $8,365 |
| Leflunomide Generic | 173 | 495 | 62 | $12K |
| Mycophenolate Mofetil Generic | 136 | 340 | 54 | $25K |
| Humira(Cf) Pen Adalimumab | 125 | 149 | 18 | $1.3M |
| Rinvoq Upadacitinib | 81 | 99 | 13 | $612K |
| Cevimeline Hcl Generic | 74 | 174 | 29 | $18K |
| Folic Acid Generic | 64 | 188 | 27 | $663 |
| Allopurinol Generic | 61 | 169 | 20 | $1,253 |
| Meloxicam Generic | 56 | 166 | 24 | $439 |
| Sulfasalazine Generic | 41 | 91 | 19 | $1,469 |
| Enbrel Etanercept | 39 | 42 | Under 11 | $314K |
| Celecoxib Generic | 36 | 96 | Under 11 | $821 |
| Pilocarpine Hcl Generic | 35 | 79 | 14 | $2,571 |
Brand drugs: 587 claims; generic drugs: 2,205 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Holly J Jones $185 ($185 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $122.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.